The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
Conditions:   COVID-19 Pneumonia;   ARDS Intervention:   Drug: Tocilizumab Sponsors:   Sciberras, Stephen M.D.;   Mater Dei Hospital, Malta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2021 Category: Research Source Type: clinical trials